Dimensional Fund Advisors
SER icon

Dimensional Fund Advisors’s Serina Therapeutics SER Stock Holding History

Dimensional Fund Advisors’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-445
Closed -$47K – 3464
2018
Q4 		$47K Buy
+445
New +$56.6K ﹤0.01% 3401

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Price Capital Management Lafayette, Louisiana $7.05M AUM 47.39% 1-Year Est. Return

Dimensional Fund Advisors's SER Position: Q1 2019 in Review

Dimensional Fund Advisors sold out of Serina Therapeutics (SER) in Q1 2019, closing a stake of 445 shares — an estimated $47K sold.

Dimensional Fund Advisors first reported a position in SER in Q4 2018 and held it in 1 quarter. The position peaked at $47K in Q4 2018. 59 funds tracked by Wall St. Rank hold SER as of Q1 2019.

  • Dimensional Fund Advisors reported no remaining Serina Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Dimensional Fund Advisors sold 445 Serina Therapeutics shares in Q1 2019, an estimated $47K.
  • Dimensional Fund Advisors first reported a position in Serina Therapeutics in Q4 2018 and held it in 1 quarter.
  • Dimensional Fund Advisors's Serina Therapeutics position peaked at $47K in Q4 2018.
  • 59 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2019.

Based on Dimensional Fund Advisors's 13F filing for Q1 2019, filed 10 May 2019.